Nimish Shah

Nimish Shah is a Partner at Venrock, where he leads investments primarily in the healthcare sector with a particular emphasis on small-cap public and crossover-stage biotechnology companies. Based in New York, Mr. Shah brings strategic insight to Venrock’s healthcare portfolio and serves as a board observer for several high-growth companies.

With over a decade of experience investing in both public and private healthcare companies, Shah’s background includes prior roles as a Research Analyst at Citadel LLC and as a Co-Founder and Board Director at Apogee Therapeutics. His expertise lies in biotechnology, pharmaceutical development, and the intersection of public and private market investing in healthcare.

Mr. Shah’s educational credentials include a Master of Business Administration from Columbia Business School and a Master of Public Health in Economics from Columbia University Mailman School of Public Health, as well as a Bachelor of Science in Pharmacy from Rutgers University. He is recognized for his rigorous approach to investment analysis and has significantly contributed to funding and guiding innovative biotech ventures.